Clinical Trial Update: Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial comparing ticagrelor to cilostazol for large-vessel ischemic stroke and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BRILINTA (ticagrelor)
• Pletal (cilostazol)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING